GeNeuro SA logo

GeNeuro SA

EPA:GNRO.PA

Overview | Financials
Company Name GeNeuro SA
Symbol GNRO.PA
Currency EUR
Price 0.077
Market Cap 2,276,362
Dividend Yield 0%
52-week-range 0.056 - 2.35
Industry Biotechnology
Sector Healthcare
CEO Mr. Jesus Martin-Garcia
Website https://www.geneuro.com

An error occurred while fetching data.

About GeNeuro SA

GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is

Related Stocks

Acticor Biotech SAS logo

Acticor Biotech SAS

ALACT.PA

0.53 EUR

Valbiotis SA logo

Valbiotis SA

ALVAL.PA

1.308 EUR

Poxel S.A. logo

Poxel S.A.

POXEL.PA

0.328 EUR

Affluent Medical SA logo

Affluent Medical SA

AFME.PA

1.675 EUR

ABIONYX Pharma SA logo

ABIONYX Pharma SA

ABNX.PA

1.196 EUR

Crossject Société Anonyme logo

Crossject Société Anonyme

ALCJ.PA

2.62 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD